STRATUMfiling intelligence๐Ÿ‡ฎ๐Ÿ‡ณ Indian private portal

CIK 1739426

RVL Pharmaceuticals plc
CIK 0001739426 ยท EDGAR โ†—
cleanelevatedtriggeredno dataplanned
83.8
composite ยท 3 signals ยท TRIGGERED

Every card below shows the score and the exact filing data it was computed from โ€” no unexplained numbers. Some signals (P-02, P-03, P-08, P-09, P-10, P-11) pull live documents from SEC EDGAR the first time you view this company; a few of those (P-03, P-10, P-11) use AI to read the filing text, but every AI claim must quote the actual document verbatim or it's discarded โ€” never a guess.

Chat with this filing โ†’

Ask follow-up questions about the latest 10-K, with citations verified against the actual text. No account needed.

Investigation memo โ€” generate one โ†’

Run the bounded investigation agent โ€” reads this company's signals and writes a short, cited summary.

Signals

P-13 ยท FY 2022-12-31 ยท TRIGGERED100.0

Zombie / distress

Zombie: interest coverage below 1.0x for 4 consecutive years
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2023-03-20) โ†—
Evidence โ€” inputs and thresholds
{
  "icr_by_year": {
    "2022-12-31": -18.968,
    "2021-12-31": -27.258,
    "2020-12-31": -22.137,
    "2019-12-31": -15.413
  },
  "consecutive_years_below_1": 4,
  "altman_z_double_prime": -14.93,
  "definitions": {
    "zombie": "ICR<1 for 3+ consecutive FYs (BIS 2018)",
    "z_distress": "<1.1 distress, 1.1-2.6 gray, >2.6 safe"
  },
  "inputs": {
    "ebit_t": -58990000,
    "interest_expense_t": 3110000
  },
  "stale": false,
  "latest_filing_period": "2022-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1739426/000155837023004211/0001558370-23-004211-index.htm",
    "form": "10-K",
    "filed": "2023-03-20"
  }
}
P-01 ยท FY 2022-12-31 ยท ELEVATED37.9

Earnings quality

Beneish M-Score -2.17 in the elevated zone
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2023-03-20) โ†—
Evidence โ€” inputs and thresholds
{
  "m_score": -2.175,
  "threshold": -1.78,
  "ratios": {
    "DSRI": 0.156,
    "GMI": 0.98,
    "AQI": 0.944,
    "SGI": 2.841,
    "DEPI": 1,
    "SGAI": 0.33,
    "LVGI": 1.42,
    "TATA": -0.108
  },
  "defaulted_to_neutral": [
    "DEPI"
  ],
  "sloan_accruals": -0.1016,
  "inputs": {
    "revenue_t": 49721000,
    "revenue_t1": 17501000,
    "total_assets_t": 128510000,
    "net_income_t": -51692000,
    "cfo_t": -37810000
  },
  "stale": false,
  "latest_filing_period": "2022-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1739426/000155837023004211/0001558370-23-004211-index.htm",
    "form": "10-K",
    "filed": "2023-03-20"
  }
}
P-12 ยท FY 2022-12-31 ยท ELEVATED40.9

Restatement predictor

F-Score 1.23 โ€” misstatement risk 1.2x the base rate
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2023-03-20) โ†—
Evidence โ€” inputs and thresholds
{
  "f_score": 1.227,
  "probability": 0.00454,
  "components": {
    "rsst": -0.1016,
    "drec": -0.0087,
    "dinv": -0.0004,
    "soft": 0.6534,
    "dcs": 1.9088,
    "droa": 0.0465,
    "issue": 1
  },
  "model": "Dechow et al. 2011, Model 1 (simplified RSST)",
  "thresholds": {
    "elevated": 1,
    "triggered": 1.85
  },
  "stale": false,
  "latest_filing_period": "2022-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1739426/000155837023004211/0001558370-23-004211-index.htm",
    "form": "10-K",
    "filed": "2023-03-20"
  }
}